Speakers
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Charlotte Tighe at c.tighe@oxfordglobal.co.uk
Confirmed speakers 2012
- Les Baillie,
Professor of Microbiology, Welsh School of Pharmacy, Cardiff University - Susan Barnett,
Senior Director, Novartis Vaccines and Diagnostics
- Cécile Bauche,
R&D Director, Theravectys - Tamar Ben-Yedidia,
CSO, Biondvax - Thomas Blanchard,
Honorary Senior Lecturer, Consultant in Infectious Diseases, Department of Virology, Manchester University - Miles Carroll,
Deputy Director, Head of Research, Health Protection Agency - Danilo Casimiro,
Director, Vaccine Research, Merck - James Cummings,
Director, Translational Medicine Branch, WRAIR, assistant Professor of Medicine, Uniformed University of Health Sciences - Parimal Desai,
Head of Manufacturing Sciences and Commercialization, Merck Vaccine - Arin Ghasparian,
Co-founder and CSO, Virometix - André Habel,
Chief Technology Officer, Themis BioScience - Rod Hafner,
SVP Research and Development, Circassia - Bassam Hallis,
General Project Manager, Health Protection Agency - Kathrin U. Jansen,
Senior Vice President, Vaccine Research East & Early Development, Pfizer - Joseph Joyce,
Director, Vaccines Basic Research, Merck Research Laboratories - Beate Kampmann,
Professor in Paediatric Infection & Immunity, NIHR Senior Research Fellow - Michael Kowarik,
Head of Research, Glycovaxyn - Alex Kudrin,
Takeda Global Research & Development Centre (Europe) Ltd., UK, Medical Director, Gastroenterology, Immunology/Inflammation and Vaccines - Mike McCarthy,
Director, Infectious Disease/Vaccines Research, MedImmune - David McIntosh,
Global Scientific Affairs Senior Expert, Novartis - Lyn Morgan,
Director Regulatory Affairs, Development Products, Sanofi Pasteur - Tarit Mukhopadhyay,
Lecturer in Vaccine Bioprocess Development, University College London - Alistair Noble,
Senior Lecturer, Kings College London - Michele Pallaoro,
Unit Head, Formulation & Delivery Department, Novartis Vaccines and Diagnostics - Athanasios Papadopoulos,
Global Clinical Research Physician – Senior Medical Advisor, Novartis Vaccines and Diagnostics - Sonia Quaratino,
Professor and Senior Medical Director and Immunology Advisor, Merck Serono, Global Clinical Development Unit, Oncology - Oliver Riede
Project Manager, DNA Vaccine Department, Mologen - Philip Roopram,
Sr. CPM Director, CPM Infectious Diseases/Vaccines, Quintiles - Elisa Scarselli,
Clinical Director, Okairos - Ulla Seppelä
Discovery Licensing Manager, Intellectual Property Rights & Licensing, ALK-Abelló, Denmark - Robin Shattock,
Professor of Mucosal Infection and Immunity, Imperial College London - De-chu Tang,
Founder, VP and CTO, Vaxin - Malcolm Thomas,
CEO, Arbovax - Amanda Versteilen
Scientist, Clinical Assays, Crucell - Stephen Ward
Development Director, Stabilitech - Tao Yuan,
Senior Scientist, Bioprocess R&D, Sanofi Pasteur, Canada
